Category Archives: Market News

GeoVax Labs, Inc. (GOVX: OTCQB) | GeoVax to Present During China Showcase at Biotech Showcase 2018

Part of Larger Corporate Partnering Effort During the J.P. Morgan 36th Annual Healthcare Conference

ATLANTA, GA, Jan. 02, 2018 (GLOBE NEWSWIRE) —  GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines and immunotherapies, announced today that its Chief Scientific Officer, Farshad Guirakhoo, PhD, will deliver a presentation at the China Showcase during the Biotech Showcase 2018 conference. Dr. Guirakhoo’s presentation will be made at 2:00 p.m. on January 7, 2018 at the Parc 55 hotel in San Francisco, California.

The China Showcase is an event for companies and investors interested in cross-border investment and strategic partnering opportunities. Dr. Guirakhoo’s presentation will focus on the broad utility and impressive dataset being developed for GeoVax’s MVA-VLP vaccine platform, and he will provide an overview of the Company’s vaccine development programs in the areas of HIV, Zika, Lassa fever, malaria, hepatitis B immunotherapy, and immuno-oncology. Following the presentation, senior management of GeoVax will be available for one-on-one meetings with investment professionals and business development representatives from the life sciences industry.

Robert McNally, PhD, GeoVax’s President CEO, commented, “While our presentation and attendance at the China Showcase is primarily focused on strategic opportunities with Chinese investors and biopharmaceutical companies, this is part of our larger effort during multiple events in San Francisco connected to the J.P. Morgan Annual Healthcare Conference on January 8-11, 2018. We continue to build a strong pipeline of preventive vaccines and immuno-therapeutics addressing multiple unmet medical needs in infectious diseases and cancer.  We look forward to connecting with many potential collaborators, partners and investors to communicate the value of our technology and the rationale for investing in the advancement of our vaccines to human clinical trials.”

Interested parties may schedule meetings with GeoVax through the conference websites for the Biotech Showcase (https://ebdgroup.knect365.com/biotech-showcase/), the Redefining Early Stage Investments (RESI) Conference (http://www.resiconference.com/), or through the partnering system hosted by the Biotechnology Innovation Organization (http://convention.bio.org/partner/). Meetings may also be scheduled by contacting Company management directly.

About GeoVax

GeoVax Labs, Inc., is a clinical-stage biotechnology company developing human vaccines against infectious diseases using its MVA-VLP vaccine platforms. The Company’s HIV vaccine for the clade B epidemic in the Americas, Australia, Japan and Europe is advancing in human trials conducted by the HIV Vaccine Trials Network (HVTN). Preclinical programs are focused on preventive vaccines for Zika virus, hemorrhagic fever viruses (Ebola, Sudan, Marburg, and Lassa), and malaria, as well as therapeutic vaccines for HIV, chronic hepatitis B infections and cancers. GeoVax’s vaccine platform supports in vivo production of non-infectious VLPs from the cells of the very person receiving the vaccine, mimicking a natural infection and effectively stimulating both the humoral and cellular arms of the immune system to recognize, prevent, and control the target infection. For more information, visit www.geovax.com.

Robert T. McNally, Ph.D.
GeoVax Labs, Inc.
investor@geovax.com
678-384-7220

Primary Logo

Article source: http://www.otcmarkets.com/stock/GOVX/news?id=179327

Bombardier Inc. (BDRBF: OTCQX International Premier) | Bombardier to Supply 17 Additional Locomotives to New Jersey

BERLIN, GERMANY–(Marketwired – Jan 2, 2018) –

Note to editors: To view the photo associated with this press release, please visit the following link: The BOMBARDIER ALP-45 Dual-Power Locomotive (Photo:Roman Porta)

Rail technology leader Bombardier Transportation announced today that New Jersey Transit Corporation (NJ TRANSIT) has exercised an option for 17 additional BOMBARDIER ALP-45 dual-power locomotives. This second call off is valued at approximately $160 million US (133 million euro) and is based on a contract for 26 locomotives signed in 2008. NJ TRANSIT exercised a first option for nine units in 2011 and the contract includes options for up to 37 more units.

“This option order is confirmation of the confidence NJ TRANSIT has in our highly innovative, energy efficient, reliable, and safe equipment,” said Benoit Brossoit, President, Americas Region, Bombardier Transportation. “The new locomotives will comply with the EPA’s Tier 4 Exhaust Limits, making them environmentally friendly which is especially important in a metropolitan area like New York.”

The dual-power locomotives are capable of operating under both diesel power and alternating current electric power from overhead sources. Their flexible power system enables the locomotives to operate across the entire NJ TRANSIT rail system, which includes both electrified and non-electrified lines, thus allowing passengers to ride a single train between New Jersey and New York Penn Station without having to change trains. Their introduction in 2011-2012 at NJ TRANSIT and the then Agence Métropolitaine de Transport in Montreal (now named Réseau de transport métropolitain) marked a first for this technology in North America.

The locomotives will be manufactured at Bombardier sites in Germany and Poland. Delivery is scheduled to start in November 2019.

NJ TRANSIT is the largest statewide public transportation system in the United States and an established customer of Bombardier. Over the years, Bombardier has provided 100 electric and dual-power locomotives, hundreds of push-pull commuter coaches, and 429 Multilevel vehicles to NJ TRANSIT. In addition, Bombardier was a member of the consortium that designed and built NJ TRANSIT’s turnkey RiverLINE light rail system between Camden and Trenton, New Jersey and now operates and maintains the system under a contract with NJ TRANSIT.

About New Jersey Transit

NJ TRANSIT is the nation’s largest statewide public transportation system providing more than 944,000 weekday trips on 252 bus routes, three light rail lines, 12 commuter rail lines and through Access Link paratransit service. It is the third largest transit system in the country with 166 rail stations, 62 light rail stations and more than 19,000 bus stops linking major points in New Jersey, New York and Philadelphia.

About Bombardier Transportation

Bombardier Transportation is a global leader in rail technology and offers the broadest portfolio in the industry. It covers the full spectrum of rail solutions, ranging from trains to sub-systems and signalling. The company also provides complete transport systems, e-mobility technology and maintenance services. As an innovation driver, Bombardier Transportation continuously breaks new ground in sustainable mobility. It provides integrated solutions that create substantial benefits for operators, passengers and the environment. Headquartered in Berlin, Germany, Bombardier Transportation employs around 37,150 people and its products and services operate in over 60 countries.

About Bombardier

Bombardier is the world’s leading manufacturer of both planes and trains. Looking far ahead while delivering today, Bombardier is evolving mobility worldwide by answering the call for more efficient, sustainable and enjoyable transportation everywhere. Our vehicles, services and, most of all, our employees are what make us a global leader in transportation.

Bombardier is headquartered in Montréal, Canada and our shares are traded on the Toronto Stock Exchange (BBD). In the fiscal year ended December 31, 2016, we posted revenues of $16.3 billion. News and information are available at bombardier.com or follow us on Twitter @Bombardier.

Notes to Editors

To receive our press releases, please visit the RSS Feed section.

Bombardier and ALP are trademarks of Bombardier Inc. or its subsidiaries.

You can also contact one of our worldwide contacts for specific press inquiries.

Article source: http://www.otcmarkets.com/stock/BDRBF/news?id=179252

Bombardier Inc. (BDRBF: OTCQX International Premier) | Bombardier to Supply 17 Additional Locomotives to New Jersey

BERLIN, GERMANY–(Marketwired – Jan 2, 2018) –

Note to editors: To view the photo associated with this press release, please visit the following link: The BOMBARDIER ALP-45 Dual-Power Locomotive (Photo:Roman Porta)

Rail technology leader Bombardier Transportation announced today that New Jersey Transit Corporation (NJ TRANSIT) has exercised an option for 17 additional BOMBARDIER ALP-45 dual-power locomotives. This second call off is valued at approximately $160 million US (133 million euro) and is based on a contract for 26 locomotives signed in 2008. NJ TRANSIT exercised a first option for nine units in 2011 and the contract includes options for up to 37 more units.

“This option order is confirmation of the confidence NJ TRANSIT has in our highly innovative, energy efficient, reliable, and safe equipment,” said Benoit Brossoit, President, Americas Region, Bombardier Transportation. “The new locomotives will comply with the EPA’s Tier 4 Exhaust Limits, making them environmentally friendly which is especially important in a metropolitan area like New York.”

The dual-power locomotives are capable of operating under both diesel power and alternating current electric power from overhead sources. Their flexible power system enables the locomotives to operate across the entire NJ TRANSIT rail system, which includes both electrified and non-electrified lines, thus allowing passengers to ride a single train between New Jersey and New York Penn Station without having to change trains. Their introduction in 2011-2012 at NJ TRANSIT and the then Agence Métropolitaine de Transport in Montreal (now named Réseau de transport métropolitain) marked a first for this technology in North America.

The locomotives will be manufactured at Bombardier sites in Germany and Poland. Delivery is scheduled to start in November 2019.

NJ TRANSIT is the largest statewide public transportation system in the United States and an established customer of Bombardier. Over the years, Bombardier has provided 100 electric and dual-power locomotives, hundreds of push-pull commuter coaches, and 429 Multilevel vehicles to NJ TRANSIT. In addition, Bombardier was a member of the consortium that designed and built NJ TRANSIT’s turnkey RiverLINE light rail system between Camden and Trenton, New Jersey and now operates and maintains the system under a contract with NJ TRANSIT.

About New Jersey Transit

NJ TRANSIT is the nation’s largest statewide public transportation system providing more than 944,000 weekday trips on 252 bus routes, three light rail lines, 12 commuter rail lines and through Access Link paratransit service. It is the third largest transit system in the country with 166 rail stations, 62 light rail stations and more than 19,000 bus stops linking major points in New Jersey, New York and Philadelphia.

About Bombardier Transportation

Bombardier Transportation is a global leader in rail technology and offers the broadest portfolio in the industry. It covers the full spectrum of rail solutions, ranging from trains to sub-systems and signalling. The company also provides complete transport systems, e-mobility technology and maintenance services. As an innovation driver, Bombardier Transportation continuously breaks new ground in sustainable mobility. It provides integrated solutions that create substantial benefits for operators, passengers and the environment. Headquartered in Berlin, Germany, Bombardier Transportation employs around 37,150 people and its products and services operate in over 60 countries.

About Bombardier

Bombardier is the world’s leading manufacturer of both planes and trains. Looking far ahead while delivering today, Bombardier is evolving mobility worldwide by answering the call for more efficient, sustainable and enjoyable transportation everywhere. Our vehicles, services and, most of all, our employees are what make us a global leader in transportation.

Bombardier is headquartered in Montréal, Canada and our shares are traded on the Toronto Stock Exchange (BBD). In the fiscal year ended December 31, 2016, we posted revenues of $16.3 billion. News and information are available at bombardier.com or follow us on Twitter @Bombardier.

Notes to Editors

To receive our press releases, please visit the RSS Feed section.

Bombardier and ALP are trademarks of Bombardier Inc. or its subsidiaries.

You can also contact one of our worldwide contacts for specific press inquiries.

Article source: http://www.otcmarkets.com/stock/BDRBF/news?id=179252

Bunk Beds